Company Quick10K Filing
Compuware Corp
10-Q 2021-03-31 Filed 2021-05-13
10-K 2020-12-31 Filed 2021-03-30
10-Q 2020-09-30 Filed 2020-11-05
10-Q 2020-06-30 Filed 2020-08-12
10-Q 2020-03-31 Filed 2020-06-26
10-K 2019-12-31 Filed 2020-03-20
10-Q 2019-09-30 Filed 2019-11-12
10-Q 2019-06-30 Filed 2019-08-13
10-Q 2019-03-31 Filed 2019-05-13
10-K 2018-12-31 Filed 2019-03-22
10-Q 2018-09-30 Filed 2018-11-13
10-Q 2018-06-30 Filed 2018-08-13
10-Q 2018-03-31 Filed 2018-05-14
S-1 2018-01-12 Public Filing
10-K 2017-12-31 Filed 2018-04-02
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-08
10-Q 2017-03-31 Filed 2017-05-08
10-K 2016-12-31 Filed 2017-04-04
10-Q 2016-09-30 Filed 2016-11-07
10-Q 2016-06-30 Filed 2016-07-27
10-Q 2016-03-31 Filed 2016-05-16
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-10-02
10-Q 2015-03-31 Filed 2015-08-31
10-Q 2014-09-30 Filed 2015-08-31
10-Q 2014-06-30 Filed 2015-08-31
10-Q 2014-03-31 Filed 2015-08-31
10-K 2013-12-31 Filed 2015-08-31
10-Q 2013-09-30 Filed 2015-08-31
10-K 2013-06-30 Filed 2015-08-31
10-Q 2013-06-30 Filed 2015-08-31
10-Q 2013-03-31 Filed 2015-08-31
10-K 2012-12-31 Filed 2015-08-31
10-Q 2012-09-30 Filed 2015-08-31
10-Q 2012-06-30 Filed 2012-08-20
10-Q 2012-03-31 Filed 2012-05-15
10-K 2011-12-31 Filed 2012-03-29
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-Q 2011-03-31 Filed 2011-05-13
10-K 2010-12-31 Filed 2011-04-13
10-Q 2010-09-30 Filed 2010-11-12
10-Q 2010-06-30 Filed 2010-08-16
10-Q 2010-03-31 Filed 2010-05-13
10-K 2009-12-31 Filed 2010-03-31
8-K 2020-05-05
8-K 2019-05-06
8-K 2018-05-22
8-K 2018-02-16
8-K 2017-12-28

Compuware Corp Financials

CPWR Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Aries I Acquisition Corp. (RAMMU)
024 Pharma (EEIG)
Beauty Health Co (VSPRW)
Aquarius I Acquisition Corp. (AQUI)
MIZUHO FINANCIAL GROUP INC (MZHOF)
Eucrates Biomedical Acquisition Corp. (EUCRW)
11 Good Energy (ELVN)
180 Life Sciences Corp. (ATNFW)
1347 Capital Corp (TFSC)
Avanti Acquisition Corp. (AVAN-WT)
CORDIA CORP (CORG)
FCCC INC (FCIC)
Biofrontera Inc. (BFRI)
Ameren Illinois Co (AILNP)
MITSUBISHI UFJ FINANCIAL GROUP INC (MBFJF)
Janus International Group, Inc. (JBI-WT)
23andMe Holding Co. (MEUSW)
OceanTech Acquisitions I Corp. (OTECU)
Palayan Resources, Inc. (PLYN)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash331912151011110449164500114272142514275188772816
Accounts Receivable231417181160420000
Inventory630
PP&E262219118750432008919218949169249231000
Assets1265541312825120916204491677001149179441,3441,0831,0259629882816
Accounts Payable3903883943974054104254074324484404454224474174894744444531862026,8468,876
Long-Term Debt31430930730230030930230030030034233732030006423,9675,0495,5676,1105,6986,6106,8786,8626,851
Liabilities1,1181,1571,2131,2911,3351,3381,3571,3841,3671,3921,3921,4061,3911,4301,4041,5181,5631,6301,6891,4591,56111,85111,72911,85412,48013,64414,42017,77817,97418,35718,829
Stockholders' Equity-992-1,101-1,172-1,260-1,306-1,313-1,345-1,384-1,358-1,376-1,390-1,405-1,347-1,338-1,398-1,511-1,556-1,630-1,689-1,458-1,547-10,934-10,785-10,510-11,397-12,619-13,459-17,769-17,886-18,329-18,812
Income Statement ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue797449585678272984122200000000000000
Cost of Revenue26955692650104030000000000
Gross Profit53-21445121451232-1751122200000
R&D4425262555262080000000
SG&A4537514037532801923172-09172021212312210231991,81822732191607084
Tax00000000000000000000000000000
Net Income-69-109-71-47-49-56-49-30-185-30-1658-55-60-164-69-78-269-61-89-797-2,251-3,978-952-1,333-1,001-232-690-694
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-34-5515-4-44-11-0-9-85-52-37-72-30-20-324-835-542-177-235-105-160
Cash Investing00-6310000-30-22-80000
Cash Financing2037-1000000503868302134957448312030456149